He Zhu1, Xinchun Zhou, Samantha Redfield, Jack Lewin, Lucio Miele. 1. Cancer Institute, University of Mississippi Medical Center Jackson, MS 39216, USA ; Department of Pathology, University of Mississippi Medical Center Jackson, MS 39216, USA.
Abstract
BACKGROUND: Emerging evidence has suggested that Notch signaling pathway may be involved in the development, progression and metastasis of prostate cancer (PCa). In the present study, we investigated the expression levels of Jagged-1 and Notch-1 in human prostate tumors and their associations with PCa progression and metastasis. METHODS: Immunohistochemistry (IHC) for Jagged-1 and Notch-1 was performed on tissue microarray (TMA) slides containing 286 formalin-fixed and paraffin-embedded (FFPE) tissue specimens with various prostatic pathologies, including benign changes, high grade prostatic intraepithelial neoplasia (HGPIN), low- and high-grade PCas as well as metastatic PCa. RESULTS: Cytoplasmic and membranous IHC scores for Jagged-1 in both metastatic PCa and high grade PCa were significantly higher than those in low grade PCa and in benign prostatic tissues. Similarly, cytoplasmic IHC scores of Notch-1 in both metastatic PCa and high grade PCa were significantly elevated compared with those observed in low grade PCa and in benign prostatic tissues. A statistically significant correlation was identified between the expression of Jagged-1 and Notch-1 in human prostatic tissues. Furthermore, significantly more highly expressed Jagged-1 in membrane was observed in Caucasian patients with high-grade or metastatic PCa (vs. African Americans) and in PCa patients with positive surgical margins (vs. negative surgical margins). CONCLUSION: Our results provide strong evidence that up-regulation of Jagged1-Notch1 signaling plays a role in PCa progression and metastasis and suggest that Jagged-1 and Notch-1 may be useful markers in distinguishing indolent and aggressive PCas.
BACKGROUND: Emerging evidence has suggested that Notch signaling pathway may be involved in the development, progression and metastasis of prostate cancer (PCa). In the present study, we investigated the expression levels of Jagged-1 and Notch-1 in humanprostate tumors and their associations with PCa progression and metastasis. METHODS: Immunohistochemistry (IHC) for Jagged-1 and Notch-1 was performed on tissue microarray (TMA) slides containing 286 formalin-fixed and paraffin-embedded (FFPE) tissue specimens with various prostatic pathologies, including benign changes, high grade prostatic intraepithelial neoplasia (HGPIN), low- and high-grade PCas as well as metastatic PCa. RESULTS: Cytoplasmic and membranous IHC scores for Jagged-1 in both metastatic PCa and high grade PCa were significantly higher than those in low grade PCa and in benign prostatic tissues. Similarly, cytoplasmic IHC scores of Notch-1 in both metastatic PCa and high grade PCa were significantly elevated compared with those observed in low grade PCa and in benign prostatic tissues. A statistically significant correlation was identified between the expression of Jagged-1 and Notch-1 in human prostatic tissues. Furthermore, significantly more highly expressed Jagged-1 in membrane was observed in Caucasian patients with high-grade or metastatic PCa (vs. African Americans) and in PCa patients with positive surgical margins (vs. negative surgical margins). CONCLUSION: Our results provide strong evidence that up-regulation of Jagged1-Notch1 signaling plays a role in PCa progression and metastasis and suggest that Jagged-1 and Notch-1 may be useful markers in distinguishing indolent and aggressive PCas.
Entities:
Keywords:
Jagged-1; Notch-1; Prostate cancer (PCa); cancer metastasis; immunohistochemistry (IHC); tissue microarray (TMA)
Authors: Pierre I Karakiewicz; James A Eastham; Markus Graefen; Ilias Cagiannos; Phillip D Stricker; Eric Klein; Thomas Cangiano; Fritz H Schröder; Peter T Scardino; Michael W Kattan Journal: Urology Date: 2005-12 Impact factor: 2.649
Authors: Qinghua Zeng; Shenglin Li; Douglas B Chepeha; Thomas J Giordano; Jong Li; Honglai Zhang; Peter J Polverini; Jacques Nor; Jan Kitajewski; Cun-Yu Wang Journal: Cancer Cell Date: 2005-07 Impact factor: 31.743
Authors: Brendan C Dickson; Anna Marie Mulligan; Hui Zhang; Gina Lockwood; Frances P O'Malley; Sean E Egan; Michael Reedijk Journal: Mod Pathol Date: 2007-06 Impact factor: 7.842
Authors: Josep Domingo-Domenech; Samuel J Vidal; Veronica Rodriguez-Bravo; Mireia Castillo-Martin; S Aidan Quinn; Ruth Rodriguez-Barrueco; Dennis M Bonal; Elizabeth Charytonowicz; Nataliya Gladoun; Janis de la Iglesia-Vicente; Daniel P Petrylak; Mitchell C Benson; Jose M Silva; Carlos Cordon-Cardo Journal: Cancer Cell Date: 2012-09-11 Impact factor: 31.743
Authors: Franziska Jundt; Ioannis Anagnostopoulos; Reinhold Förster; Stephan Mathas; Harald Stein; Bernd Dörken Journal: Blood Date: 2002-05-01 Impact factor: 22.113
Authors: Leandro E Mainetti; Xiaoning Zhe; Jonathan Diedrich; Allen D Saliganan; Won Jin Cho; Michael L Cher; Elisabeth Heath; Rafael Fridman; Hyeong-Reh Choi Kim; R Daniel Bonfil Journal: Int J Cancer Date: 2014-05-20 Impact factor: 7.396
Authors: Tanya Stoyanova; Mireille Riedinger; Shu Lin; Claire M Faltermeier; Bryan A Smith; Kelvin X Zhang; Catherine C Going; Andrew S Goldstein; John K Lee; Justin M Drake; Meghan A Rice; En-Chi Hsu; Behdokht Nowroozizadeh; Brandon Castor; Sandra Y Orellana; Steven M Blum; Donghui Cheng; Kenneth J Pienta; Robert E Reiter; Sharon J Pitteri; Jiaoti Huang; Owen N Witte Journal: Proc Natl Acad Sci U S A Date: 2016-09-30 Impact factor: 11.205